Symbol: DRREDDY
Month: 2024-10
Start Price: ₹1349.82
End Price: ₹1274.20
12M Return: -5.60%
6M Return: -5.60%
3M Return: -5.60%
Volatility: 0.179
Sharpe Ratio: -3.772
Max Drawdown: -0.074
Peer Correlation (DIVISLAB): 0.2069
Peer Correlation (SUNPHARMA): 0.5533
Peer Correlation (HINDUNILVR): 0.1126
Average Peer Correlation: 0.2909

Generate a short summary and suggest whether to BUY, SELL, or HOLD.

--- LLM Output ---
**Summary:**

Dr. Reddy's Laboratories (DRREDDY) has experienced a decline in its stock price over the past 12 months, with a return of -5.60%. The stock's volatility is moderate at 0.179, and its Sharpe Ratio is -3.772, indicating a poor risk-adjusted return. The maximum drawdown is -0.074, suggesting a relatively stable performance. In terms of peer correlation, DRREDDY has a moderate correlation with SUNPHARMA (0.5533) and a low correlation with DIVISLAB (0.2069) and HINDUNILVR (0.1126).

**Recommendation:**

Based on the current performance metrics, I would suggest a **HOLD** rating for Dr. Reddy's Laboratories (DRREDDY). The stock's poor returns over the past 12 months, coupled with a negative Sharpe Ratio, indicate that it may not be an attractive investment opportunity at present. However, the moderate volatility and relatively stable performance suggest that it may not be a high-risk investment either. It's essential to monitor the company's future performance and industry trends before making a buy or sell decision. Additionally, considering the peer correlations, investors may want to diversify their portfolio by investing in other pharmaceutical companies with a lower correlation with DRREDDY.